LRRC14B Inhibitors
LRRC14B inhibitors represent a class of chemical compounds that specifically target and inhibit the activity of the leucine-rich repeat-containing protein 14B (LRRC14B). This protein is part of the leucine-rich repeat (LRR) family, which is characterized by their role in protein-protein interactions and cellular signaling. LRRC14B, like other LRR-containing proteins, contains repeated sequences that are rich in leucine residues, forming an arc or horseshoe structure that is commonly involved in mediating interactions between proteins. The inhibition of LRRC14B can be achieved through small molecules or other inhibitory agents designed to interfere with its functional domains, which may disrupt its ability to bind with other cellular targets or affect signaling pathways where LRRC14B plays a role.
The mechanism of action of LRRC14B inhibitors can vary depending on the nature of the inhibitor and its specific interaction with the protein. Some inhibitors might block the LRR domains directly, thereby preventing the interaction of LRRC14B with its binding partners. Others may act by destabilizing the protein's structure, leading to altered cellular localization or degradation of the protein. The inhibition of LRRC14B could potentially influence a range of cellular processes such as intracellular signaling, protein stability, and protein complex formation, given the diverse functions of LRR proteins in cell biology. Understanding how LRRC14B inhibitors interact with their target protein requires a detailed analysis of the protein's structure, the conformational changes upon inhibitor binding, and the downstream effects on cellular pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate acts as a competitive inhibitor of dihydrofolate reductase, leading to reduced purine synthesis. As purines are necessary for ATP synthesis, this reduction can decrease the energy available for the proper functioning of leucine rich repeat containing 14B, which relies on ATP for its activity. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Allopurinol is an inhibitor of xanthine oxidase, a key enzyme in purine catabolism. By inhibiting xanthine oxidase, allopurinol can reduce the production of uric acid and alter purine metabolism, which may inhibit the purine-dependent processes necessary for the function of leucine rich repeat containing 14B. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
Phenylarsine oxide binds to vicinal thiol groups, which can be involved in protein-protein interactions. By binding to these groups, this chemical can inhibit the interaction of leucine rich repeat containing 14B with other proteins, thus inhibiting its function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By inhibiting tyrosine kinases, it can disrupt signaling pathways that rely on the phosphorylation of tyrosine residues, which may be necessary for the activation or function of leucine rich repeat containing 14B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. PI3K signaling is vital for numerous cellular functions. Inhibition of PI3K can prevent the phosphorylation of downstream proteins that may be crucial for the functional activity of leucine rich repeat containing 14B. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK), which is upstream of extracellular signal-regulated kinases (ERK). This inhibition can disrupt signal transduction pathways that could be essential for the regulatory functions of leucine rich repeat containing 14B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase, which is involved in inflammatory responses and cell cycle regulation. Inhibition of p38 MAP kinase can impair signaling pathways that may be necessary for the functional activity of leucine rich repeat containing 14B, specifically if leucine rich repeat containing 14B is part of the inflammation or stress response pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can disrupt downstream signaling pathways. By inhibiting PI3K, wortmannin can prevent the phosphorylation of proteins that may be required for the activity of leucine rich repeat containing 14B. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which prevents the activation of ERK1/2. By inhibiting this pathway, U0126 can disrupt the signal transduction necessary for the function of leucine rich repeat containing 14B, such as cellular responses to growth factors or stress signals. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and inhibits the mammalian target of rapamycin (mTOR), a key regulator of cell growth and proliferation. Inhibition of mTOR signaling can reduce cellular activities that may be essential for the proper functioning of leucine rich repeat containing 14B, especially if it is involved in growth factor signaling. | ||||||